Pacific Edge (ASX: PEB) Share Price

$0.26

About Pacific Edge Limited

Pacific Edge Limited, a cancer diagnostics firm headquartered in Dunedin, New Zealand, and established in 2001, is dedicated to the research, development, and commercialization of advanced diagnostic and prognostic tools. These innovations are designed for the early identification and ongoing management of various cancers, with the company's activities spanning New Zealand, the United States, Australia, and Singapore. Its operations are divided into distinct Commercial and Research segments. Central to its product offerings is Cxbladder, a suite of genomic urine tests specifically tailored for the detection and clinical management of bladder cancer. The company is actively expanding this portfolio with several new developments: Cxbladder Resolve, which aims to identify patients likely to have aggressive or more advanced bladder cancer; Cxbladder Triage, designed to flag individuals with haematuria who have a low probability of bladder cancer; Cxbladder Detect, enabling the non-invasive discovery of bladder and other urinary tract cancers; and Cxbladder Monitor, a tool for urologists to track bladder cancer recurrence in patients. In addition to its focus on bladder cancer, Pacific Edge is also progressing with Cxcolorectal, a prognostic gene signature intended for patients diagnosed with stage II or stage III colorectal cancers. Furthermore, the company's development pipeline includes products targeting diagnostics for bladder, gastric, colorectal, and endometrial cancers, as well as melanoma.

Key Financial Data

PEB Frequently Asked Questions

Latest News

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
SPLStarpharma Holdings Limited	$286.2M	$0.68	27.58	0.00%	▲+1.49%
ONEOneview Healthcare PLC	$149.6M	$0.17	-9.06	0.00%	▲+4.62%
EMVEMVision Medical Devices Ltd	$145.9M	$1.57	-10.00	0.00%	▼-1.88%
ALCAlcidion Group Limited	$134.4M	$0.10	26.51	0.00%	–+0.00%
AVHAVITA Medical, Inc.	$134.2M	$1.08	-26.62	0.00%	▼-5.68%
NYRNyrada Inc.	$87.9M	$0.44	-20.63	0.00%	▼-2.22%
AHCAustco Healthcare Limited	$84.3M	$0.225	7.70	0.00%	▲+2.27%
LDXLumos Diagnostics Holdings Limited	$80.2M	$0.105	-7.39	0.00%	▲+6.06%

ETFs That Hold PEB

PEB is held by 4 ASX-listed funds tracked on this site. The largest allocation is in iShares S&P Small-Cap ETF (ASX: IJR) at 0.09% of its portfolio.

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices